Literature DB >> 8535400

Inhibitory effect of pyridobenzazoles on virus replication in vitro.

T Chiba1, S Shigeta, Y Numazaki.   

Abstract

Twelve species of pyridobenzazoles and pyrimidobenzimidazole were examined as inhibitors of the replication of respiratory syncytial virus (RSV) in HeLa cells. From the pyridobenzazoles studied, 2-benzamido-4-cyano-1-oxo-1H,5H-pyrido[1,2-alpha]benzimidazol emerged as a potent inhibitor of the RSV. Based on its inhibitory effect on the cytopathogenicity of the RSV in HeLa cells, the 50% effective dose was found to be 0.95 micrograms/ml. The cytotoxicity of this compound for HeLa cells was examined by monitoring the incorporation of radiolabeled uridine into cellular RNA. The selectivity index was ca. 30, the same as Virazole.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8535400     DOI: 10.1248/bpb.18.1081

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  3 in total

Review 1.  Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment.

Authors:  J B Domachowske; H F Rosenberg
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  Generation of 500-member library of 10-alkyl-2-R(1),3-R(2)-4,10-dihydrobenzo[4,5]imidazo[1,2-alpha]pyrimidin-4-ones.

Authors:  Svetlana M Sirko; Nikolay Yu Gorobets; Vladimir I Musatov; Sergey M Desenko
Journal:  Molecules       Date:  2009-12-15       Impact factor: 4.411

3.  One-Pot Synthesis of Benzo[4,5]imidazo[1,2-a]pyrimidin-2-ones Using a Hybrid Catalyst Supported on Magnetic Nanoparticles in Green Solvents.

Authors:  Alkassoume Moussa; Abbas Rahmati
Journal:  ChemistryOpen       Date:  2021-08       Impact factor: 2.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.